Scarica l'app Stockscreener
3.85
2.04%
-0.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SANA Giù?
Forum
Previsione
Precedente Chiudi:
$3.93
Aprire:
$3.94
Volume 24 ore:
2.90M
Relative Volume:
0.75
Capitalizzazione di mercato:
$1.07B
Reddito:
-
Utile/perdita netta:
$-241.99M
Rapporto P/E:
-4.1005
EPS:
-0.9389
Flusso di cassa netto:
$-133.64M
1 W Prestazione:
-3.99%
1M Prestazione:
+36.52%
6M Prestazione:
-15.57%
1 anno Prestazione:
-5.17%
Intervallo 1D:
$3.635
$3.95
Intervallo di 1 settimana:
$3.635
$4.21
Portata 52W:
$2.61
$6.55
Sana Biotechnology Inc Stock (SANA) Company Profile
Nome
Sana Biotechnology Inc
Settore
Industria
Telefono
(206) 701-7914
Indirizzo
188 EAST BLAINE STREET, SUITE 350, SEATTLE
Compare SANA vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
3.85 | 1.07B | 0 | -241.99M | -133.64M | -0.9389 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-24 | Iniziato | Wedbush | Outperform |
| 2025-07-03 | Ripresa | Morgan Stanley | Overweight |
| 2025-03-18 | Aggiornamento | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | Iniziato | Jefferies | Buy |
| 2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-11-05 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | Iniziato | Rodman & Renshaw | Buy |
| 2024-01-16 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-09-05 | Iniziato | Citigroup | Buy |
| 2023-08-14 | Iniziato | TD Cowen | Market Perform |
| 2023-05-02 | Iniziato | H.C. Wainwright | Neutral |
| 2021-03-01 | Iniziato | BofA Securities | Buy |
| 2021-03-01 | Iniziato | Goldman | Neutral |
| 2021-03-01 | Iniziato | JP Morgan | Neutral |
| 2021-03-01 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Sana Biotechnology Inc Borsa (SANA) Ultime notizie
Securities Lawsuit Alert: Sana Biotechnology, Inc. (SANA)Contact Levi & Korsinsky Before May 20, 2025 - The National Law Review
Sana Biotechnology (SANA) Is Up 18.1% After Removal From Key Russell Value IndexesWhat's Changed - simplywall.st
Sana Biotech heads to EASD with diabetes cell therapy update - Longevity.Technology
Sana Biotechnology (SANA) H.C. Wainwright 27th Annual Global Investment Conference summary - Quartr
Sana Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Bishop Hans Edgar - Moomoo
Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - AOL.com
Form 4 Sana Biotechnology Inc For: 7 July By Investing.com - Investing.com Nigeria
Sana Biotechnology (SANA) director Hans Bishop receives 6,297 vested RSU shares - Stock Titan
SANA Should I Buy - Intellectia AI
Will Removal From Russell Value Benchmarks Change Sana Biotechnology's (SANA) Institutional Investor Narrative? - Sahm
Sana Biotechnology (SANA) Proxy filing Summary - Quartr
Sana Biotechnology (SANA) Q1 2026 earnings summary - Quartr
Sana to show first-in-human islet transplant data without immunosuppression - Stock Titan
Citizens reiterates Sana Biotechnology stock rating on IND filing By Investing.com - Investing.com Canada
Sana Biotechnology, Inc.(NasdaqGS:SANA) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
Sana Biotechnology, Inc.(NasdaqGS: SANA) dropped from Russell 3000 Value Benchmark - marketscreener.com
Sana Biotechnology, Inc.(NasdaqGS: SANA) dropped from Russell 3000E Value Benchmark - marketscreener.com
Sana Biotechnology, Inc.(NasdaqGS: SANA) dropped from Russell 2500 Value Benchmark - marketscreener.com
Join Class Action to Recover Losses from Sana Biotechnology, Inc - The National Law Review
Lost Money on Sana Biotechnology, Inc. (SANA)? Contact Levi & Korsinsky to Join Class Action Before May 20, 2025 - The National Law Review
Enterprise value to EBIT forward of Sana Biotechnology, Inc. – NASDAQ:SANA - TradingView
SANA BIOTECHNOLOGY INC (SANA) Stock Chart - ChartMill
Price to earnings forward of Sana Biotechnology, Inc. – NASDAQ:SANA - TradingView
Sana Biotechnology, Inc. Actuals & Estimates (NASDAQ:SANA) - TradingView
SANA Forecast — Price Target — Prediction for 2027 - TradingView
SANA News | SANA BIOTECHNOLOGY INC (NASDAQ:SANA) - ChartMill
Sana Biotechnology Inc (SANA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sana Biotechnology Inc (SANA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sana Biotechnology Inc (SANA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
SANA Q1 2026 Earnings: Narrower-than-Expected Loss Drives Shares HigherEarnings Beat Streak - dars.gov.et
Sana Biotechnology Inc (SANA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sana Biotechnology Inc (SANA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Sana Biotechnology Inc (SANA) Institutional Confidence - TradingKey
Sana Biotechnology Inc (SANA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Sana Biotechnology Inc (SANA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Sana Biotechnology Inc (SANA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Sana Biotechnology, Inc. Stock 12‑Month Price Target Cut to $9.14, Implies 230% Upside - TradingView
Sana Biotechnology raises $69M through ATM share sale - MSN
Harbour BioMed Appoints Dr. Dhavalkumar Patel as Scientific Advisor - Yahoo Finance
Sana Biotechnology (SANA) Holds Steady at $2.82 Amid Key Technical RangePut Wall - dars.gov.et
SANA: Gene-modified islet and in vivo CAR T therapies advance toward pivotal trials and key data in 2024 - TradingView
Sana Biotechnology (SANA) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
Sana Biotechnology, Inc. - MLQ.ai
SANA SEC FilingsSana Biotechnology, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Sana Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Bilenker Joshua H. - Moomoo
Sana Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director NELSEN ROBERT - Moomoo
Sana Biotechnology Shareholders Reelect Directors and Ratify Auditor - TipRanks
Sana Biotechnology (SANA) director awarded options for 90,000 shares at $2.96 - Stock Titan
Sana Biotechnology (SANA) director granted 90,000 stock options at $2.96 strike - Stock Titan
Director Michelle Seitz gets 90,000 Sana (SANA) stock options - Stock Titan
Sana Biotechnology (SANA) grants director 90,000 stock options at $2.96 - Stock Titan
Sana Biotechnology Inc Azioni (SANA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Sana Biotechnology Inc Azioni (SANA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Harr Steve | President & CEO |
Mar 06 '26 |
Option Exercise |
0.00 |
41,666 |
0 |
7,918,596 |
| Wyrick Susan D. | See Remarks |
Mar 07 '26 |
Option Exercise |
0.00 |
3,250 |
0 |
200,583 |
| Wyrick Susan D. | See Remarks |
Mar 06 '26 |
Option Exercise |
0.00 |
10,416 |
0 |
197,333 |
| Wyrick Susan D. | See Remarks |
Mar 02 '26 |
Option Exercise |
0.00 |
1,525 |
0 |
187,408 |
| Wyrick Susan D. | See Remarks |
Jan 02 '26 |
Option Exercise |
0.00 |
7,500 |
0 |
188,290 |
| Wyrick Susan D. | See Remarks |
Dec 13 '25 |
Option Exercise |
0.00 |
3,400 |
0 |
181,663 |
| Wyrick Susan D. | See Remarks |
Dec 03 '25 |
Option Exercise |
0.00 |
10,000 |
0 |
180,828 |
2.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):